Status:
COMPLETED
Evaluation of IgY Antibody Efficacy in Egg Yolk Against Helicobacter Pylori in Bacterial Elimination and Clinical Symptoms Improvement of Gastrointestinal Patients
Lead Sponsor:
Mashhad University of Medical Sciences
Conditions:
HELICOBACTER PYLORI INFECTIONS
Gastrointestinal Disease
Eligibility:
All Genders
18-78 years
Phase:
PHASE2
Brief Summary
1. Investigating its effectiveness in removing bacteria in invivo conditions 2. Investigating the effectiveness in improving the clinical symptoms of patients
Eligibility Criteria
Inclusion
- Patients with gastritis or stomach ulcers whose Helicobacter infection has been confirmed by a doctor and age group 18 to 78 years, all genders, if accepted
Exclusion
- Acute perforation of esophagus, stomach and duodenum Hyperlipidemic people Those who are allergic to egg proteins Patients with stomach cancer
Key Trial Info
Start Date :
December 4 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 21 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06973889
Start Date
December 4 2023
End Date
January 21 2025
Last Update
May 15 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Mashhad University of Medical Sciences
Mashhad, Khorasan, Iran, 9177945418
2
Mashhad university of medical sciences
Mashhad, Khorasan, Iran, 9177948564